Behavioural phenotyping of knockout mice for the sigma-1 (σ1) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations

Journal of Psychopharmacology

Volumn 25, Issue 7, 2011, Pages 960-975

  Chevallier, Nathalie ^a   Keller, Emeline ^a   Maurice, Tangui ^a  

^a University of Montpellier   (France)

Author keywords

1 chaperone protein; Anxiety; behavioural despair; gender related differences; learning and memory

Indexed keywords

AMITRIPTYLINE; CHAPERONE; DESIPRAMINE; ESTRADIOL; FLUOXETINE; IGMESINE; IMIPRAMINE; SERTRALINE; SIGMA 1 CHAPERONE PROTEIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; ESTRADIOL BLOOD LEVEL; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; KNOCKOUT MOUSE; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEX DIFFERENCE; SPATIAL MEMORY;

AGE FACTORS; AGING; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CINNAMATES; CYCLOPROPANES; DEPRESSION; ESCAPE REACTION; ESTRADIOL; FEMALE; GENOTYPE; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PHENOTYPE; REACTION TIME; RECEPTORS, SIGMA; SEX FACTORS; TIME FACTORS;

EID: 80051960144     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111400648     Document Type: Article

References (59)

1. Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M, et al. Immunocytochemical localization of the σ1 receptor in the adult rat central nervous system. Neuroscience. 2000 ; 97: 155-170 (Pubitemid 30195885)
2. Bergeron R, de Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci. 1996 ; 16: 1193-1202 (Pubitemid 26140876)
3. Cendán CM, Pujalte JM, Portillo-Salido E, Montoliu L, Baeyens JM. Formalin-induced pain is reduced in sigma1 receptor knockout mice. Eur J Pharmacol. 2005 ; 511: 73-74 (Pubitemid 40380646)
4. Cobos EJ, Entrena JM, Nieto FR, Cendán CM, Pozo Del E. Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol. 2008 ; 6: 344-366
5. Egashira N, Harada S, Okuno R, Matsushita M, Nishimura R, Mishima K, et al. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine. Eur J Pharmacol. 2007 ; 563: 149-154 (Pubitemid 46602243)
6. Entrena JM, Cobos EJ, Nieto FR, Cendán CM, Gris G, Pozo Del E, et al. Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain. 2009 ; 143: 252-261
7. Espallergues J, Lapalud P, Christopoulos A, Avlani VA, Sexton PM, Vamvakides A, et al. Involvement of the sigma1 (σ1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. Br J Pharmacol. 2007 ; 152: 267-279 (Pubitemid 47517609)
8. Foy MR, Baudry M, Diaz Brinton R, Thompson RF. Estrogen and hippocampal plasticity in rodent models. J Alzheimers Dis. 2008 ; 15: 589-603
9. Hashimoto K, Fujita Y, Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology. 2007 ; 32: 514-521
10. Hayashi T, Su TP. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci U S A. 2001 ; 98: 491-496 (Pubitemid 32105069)
11. Hayashi T, Su TP. Sigma-1 receptors (σ1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther. 2003a ; 306: 718-725 (Pubitemid 36886173)
12. Hayashi T, Su TP. Intracellular dynamics of sigma-1 receptors (σ1 binding sites) in NG108-15 cells. J Pharmacol Exp Ther. 2003b ; 306: 726-733 (Pubitemid 36886174)
13. Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell. 2007 ; 131: 596-610 (Pubitemid 350017760)
14. Hill RA, Boon WC. Estrogens, brain, and behavior: lessons from knockout mouse models. Semin Reprod Med. 2009 ; 27: 218-228
15. Ishikawa M, Sakata M, Ishii K, Kimura Y, Oda K, Toyohara J, et al. High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol. 2009 ; 12: 1127-1131
16. Ishima T, Nishimura T, Iyo M, Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 1656-1659
17. Iyo M, Shirayama Y, Watanabe H, Fujisaki M, Miyatake R, Fukami G, et al. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 1072-1073 (Pubitemid 351609231)
18. Kamei H, Kameyama T, Nabeshima T. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma1 sites. Eur J Pharmacol. 1996 ; 299: 21-28
19. Kamei H, Noda Y, Kameyama T, Nabeshima T. Role of (+)-SKF-10,047- sensitive sub-population of sigma1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems. Eur J Pharmacol. 1997 ; 319: 165-172 (Pubitemid 27056035)
20. King M, Pan YX, Mei J, Chang A, Xu J, Pasternak GW. Enhanced κ-opioid receptor-mediated analgesia by antisense targeting the σ1 receptor. Eur J Pharmacol. 1997 ; 331: R5 - R6
21. Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma1 (σ1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat. 2000 ; 20: 375-387 (Pubitemid 32162893)
22. Langa F, Codony X, Tovar V, Lavado A, Giménez E, Cozar P, et al. Generation and phenotypic analysis of sigma receptor type I (sigma1) knockout mice. Eur J Neurosci. 2003 ; 18: 2188-2196 (Pubitemid 38117392)
23. Liu F, Day M, Muñiz LC, Bitran D, Arias R, Revilla-Sanchez R, et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 2008 ; 11: 334-343 (Pubitemid 351311804)
24. Matsuno K, Kobayashi T, Tanaka MK, Mita S. Sigma1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol. 1996 ; 312: 267-271 (Pubitemid 26323508)
25. Maurice T. Beneficial effect of the sigma1 receptor agonist PRE-084 against the spatial learning deficits in aged rats. Eur J Pharmacol. 2001 ; 431: 223-227 (Pubitemid 33132129)
26. Maurice T Sigma Receptors. Chemistry, Cell Biology and Clinical Implications. Matsumoto RR Bowen WD Su TP, ed. New York: Springer Science+Business Media ; 2007: 273-292.
27. Maurice T, Grégoire C, Espallergues J. Neuro(active)steroids actions at the neuromodulatory sigma1 (σ1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav. 2006 ; 84: 581-597 (Pubitemid 350061234)
28. Maurice T, Junien JL, Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via σ1-receptors. Behav Brain Res. 1997 ; 83: 159-164 (Pubitemid 27086630)
29. Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabeshima T. Neuroactive neurosteroids as endogenous effectors for the sigma1 (σ1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol. 1999 ; 81: 125-155 (Pubitemid 29532972)
30. Maurice T, Phan VL, Privat A. The anti-amnesic effects of sigma1 (σ1) receptor agonists confirmed by in vivo antisense strategy in the mouse. Brain Res. 2001 ; 898: 113-121 (Pubitemid 32274198)
31. Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther. 2009 ; 124: 195-206
32. Maurice T, Su TP, Parish DW, Privat A. Prevention of nimodipine-induced impairment of learning by the selective sigma ligand PRE-084. J Neural Transm Gen Sect. 1995 ; 102: 1-18
33. Maurice T, Su P, Privat A. Sigma1 (σ1) receptor agonists and neurosteroids attenuate β25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 1998 ; 83: 413-428
34. Maurice T, Villard V, Meunier J Involvement of the Sigma1 Protein in the Acute Effects of Antidepressants. San Diego, CA: Society for Neuroscience ; 2004 :
35. Mavlyutov TA, Epstein ML, Anders A, Ziskind-Conhaim L, Ruoho AE. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience. 2010 ; 167: 247-255
36. Meunier J, Ieni J, Maurice T. The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor. Br J Pharmacol. 2006 ; 149: 998-1012 (Pubitemid 44950803)
37. Monnet FP, Mahe V, Robel P, Baulieu EE. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA. 1995 ; 92: 3774-3778
38. Monnet FP, Maurice T. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. J Pharmacol Sci. 2006 ; 100: 93-118 (Pubitemid 43276943)
39. Monnet FP, Morin-Surun MP, Leger J, Combettes L. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. J Pharmacol Exp Ther. 2003 ; 307: 705-712 (Pubitemid 37310687)
40. Morin-Surun MP, Collin T, Denavit-Saubié M, Baulieu E-E, Monnet FP. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci U S A. 1999 ; 96: 8196-8199 (Pubitemid 29328431)
41. Narita N, Hashimoto K, Tomitaka S, Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol. 1996 ; 307: 117-119 (Pubitemid 26226293)
42. Nishimura T, Ishima T, Iyo M, Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One. 2008 ; 3: e2558 - e2558
43. Noda Y, Kamei H, Kamei Y, Nagai T, Nishida M, Nabeshima T. Neurosteroids ameliorate conditioned fear stress: an association with sigma receptors. Neuropsychopharmacology. 2000 ; 23: 276-284 (Pubitemid 30609661)
44. Palacios G, Muro A, Vela JM, Molina-Holgado E, Guitart X, Ovalle S, et al. Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. Brain Res. 2003 ; 961: 92-99 (Pubitemid 36084473)
45. Palacios G, Muro A, Verdu E, Pumarola M, Vela JM. Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve. Brain Res. 2004 ; 1007: 65-70 (Pubitemid 38520173)
46. Robichaud M, Debonnel G. Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids. J Endocrinol. 2004 ; 182: 11-21 (Pubitemid 39076898)
47. Rogóz Z, Skuza G. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Pharmacol Rep. 2006 ; 58: 493-500 (Pubitemid 44383274)
48. Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP. Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res. 2009 ; 198: 472-476
49. Schmidt A, Lebel L, Koe BK, Seeger T, Heym J. Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain. Eur J Pharmacol. 1989 ; 165: 335-336 (Pubitemid 19181808)
50. Senda T, Matsuno K, Okamoto K, Kobayashi T, Nakata K, Mita S. Ameliorating effect of SA4503, a novel σ1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol. 1996 ; 315: 1-10 (Pubitemid 26390943)
51. Sherwin BB. Estrogen and memory in women: how can we reconcile the findings?. Horm Behav. 2005 ; 47: 371-375 (Pubitemid 40222746)
52. Smith CC, Vedder LC, McMahon LL. Estradiol and the relationship between dendritic spines, NR2B containing NMDA receptors, and the magnitude of long-term potentiation at hippocampal CA3-CA1 synapses. Psychoneuroendocrinology. 2009 ; 34(Suppl 1): S130 - S142
53. Su TP, London ED, Jaffe JH. Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems. Science. 1988 ; 240: 219-221
54. Takebayashi M, Hayashi T, Su TP. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J Pharmacol Exp Ther. 2002 ; 303: 1227-1237 (Pubitemid 35424409)
55. Urani A, Roman FJ, Phan VL, Su TP, Maurice T. The antidepressant-like effect induced by sigma1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther. 2001 ; 298: 1269-1279 (Pubitemid 32761949)
56. Urani A, Romieu P, Roman FJ, Maurice T. Enhanced antidepressant effect of sigma1 (σ1) receptor agonists in β25-35-amyloid peptide-treated mice. Behav Brain Res. 2002 ; 134: 239-247 (Pubitemid 34912703)
57. Wilbert-Lampen U, Seliger C, Trapp A, Straube F, Plasse A. Female sex hormones decrease constitutive endothelin-1 release via endothelial sigma-1/cocaine receptors: an action independent of the steroid hormone receptors. Endothelium. 2005 ; 12: 185-191 (Pubitemid 41600863)
58. Yagasaki Y, Numakawa T, Kumamaru E, Hayashi T, Su TP, Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem. 2006 ; 281: 12941-12949 (Pubitemid 43855387)
59. Yamada M, Nishigami T, Nakasho K, Nishimoto Y, Miyaji H. Relationship between sigma-like site and progesterone-binding site of adult male rat liver microsomes. Hepatology. 1994 ; 20: 1271-1280 (Pubitemid 24323577)